NASH PASS is an IRB-approved clinical protocol that provides healthcare providers and clinical trial sites access to NASH expertise and imaging tools to identify and diagnose patients at-risk for fatty liver disease. The NASH PASS program also provides qualified principal investigators and diagnosed patients the opportunity to participate in clinical trials investigating new NAFLD and NASH drug candidates.
During this seven-minute webinar, the speakers will provide a brief introduction of the NASH PASS program from the perspective of becoming a NASH PASS clinical trial site.
Director, Clinical Strategies & Logistics, ProSciento, Inc.
Heidi Guthrie is Director of Clinical Strategies and Logistics at ProSciento, Inc. Her career in the CRO industry and clinical trial management for metabolic diseases spans more than 15 years. Her operational and therapeutic experience has led to a robust expertise is building strategic business processes for increased efficiencies across the company’s broad site network.
In her current role, Ms. Guthrie is a member of the Senior Leadership Team and manages clinical operations governance and strategic vendor management for the company’s CRO projects. She is also a member of the oversight committee for ProSciento’s NASH PASS™ program. Prior to this role, Ms. Guthrie was Associate Director of CRO Services, overseeing functional service lines and clinical project management within ProSciento’s CRO division. Earlier in her career, she was a Clinical Project Manager at ProSciento for seven years where she gained the clinical study and site network coordination experience that contributes to the client-focused insight she brings to her current leadership role.
Heidi can be contacted at Heidi.Guthrie@prosciento.com
Manager, Clinical Strategies and Logistics, ProSciento, Inc.
Kristin Stanley is the Manager of Clinical Strategies & Logistics at ProSciento, Inc. Her career in clinical research spans more than 10 years and includes roles in both the clinical research unit and CRO. Kristin has managed multiple clinical trials both in new diabetic medications and devices, as well as contributed to the development and oversight of the NASH PASS™ program. She has participated as a member of the management team driving new goals and indicators of key performance in both the CRO and CRU teams. Additionally Kristin has served as team leader for company wide fundraising initiatives resulting in the ProSciento team being a key contributor to the American Diabetes Association annual fundraiser, Tour De Cure.
Kristin can be contacted at Kristin.Stanley@prosciento.com
- For additional information about the NASH PASS program, please visit www.nashpass.com or email email@example.com.
Related webinars that may also be of interest:
- Expediting NASH Clinical Trials and Biomarker Research: NASH PASS, a Growing Clinical Research and Patient Registry Platform
- NASH Clinical Drug Development – Imaging the Liver and Beyond